| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 05/22/1998 | WO1998021345A1 Hsv/aav hybrid amplicon vectors |
| 05/22/1998 | WO1998021186A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 05/22/1998 | WO1998021183A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 05/22/1998 | WO1998020906A2 Treatment of diabetes with transcription factor gene |
| 05/22/1998 | CA2271777A1 Hsv/aav hybrid amplicon vectors |
| 05/22/1998 | CA2271116A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 05/22/1998 | CA2271100A1 Treatment of diabetes with transcription factor gene |
| 05/20/1998 | EP0842165A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
| 05/20/1998 | CN1182358A Triacetin as transdermal penetration enhancer |
| 05/19/1998 | US5753694 Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS) |
| 05/13/1998 | EP0840738A1 Colchicine derivatives, the use thereof and formulations containing them |
| 05/13/1998 | EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 05/13/1998 | CN1181258A Traumatic paraplegia pills or capsules |
| 05/12/1998 | US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus |
| 05/12/1998 | US5750137 Drug delivery, permeability, glycerides and lactates |
| 05/07/1998 | WO1998018916A1 Human p2x purinoreceptor |
| 05/07/1998 | WO1998000173A3 Targeted drug delivery using sulfonamide derivatives |
| 05/07/1998 | CA2268750A1 Human p2x purinoreceptor |
| 05/06/1998 | EP0839195A1 Nucleotide and peptide sequences for treating myasthenia |
| 05/06/1998 | EP0707570B1 Isoquinoline derivatives as therapeutic agents |
| 05/06/1998 | EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 05/06/1998 | CN1181075A Substituted isoxazoles for the treatment of inflammation |
| 05/05/1998 | US5747065 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
| 04/29/1998 | EP0837690A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least one basic amino acid residue and at least one acid amino acid residue |
| 04/23/1998 | WO1998016644A1 Fibroblast growth factor homologs |
| 04/22/1998 | EP0836849A2 Pharmaceutical formulations containing gamma amino butyric acid, an anti-oxidant, folic acid, nicotinamide and a lithium salt |
| 04/22/1998 | EP0836606A1 Condensed thiazole derivatives, having 5-ht receptor affinity |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 04/14/1998 | US5738873 Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia |
| 04/02/1998 | WO1998013492A2 Isolation and use of motoneuronotrophic factors |
| 04/01/1998 | EP0453515B1 Composition for treatment of senile dementia |
| 03/27/1998 | CA2216479A1 Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia |
| 03/26/1998 | WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/26/1998 | WO1998011885A1 Reflux inhibitors |
| 03/26/1998 | CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/25/1998 | CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine |
| 03/19/1998 | WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 03/19/1998 | CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 03/18/1998 | EP0828851A2 Tripeptidylpeptidase inhibitors |
| 03/12/1998 | WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 03/12/1998 | WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 03/12/1998 | CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 03/11/1998 | EP0633879B1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
| 03/05/1998 | WO1998008850A1 Spirocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives |
| 03/05/1998 | WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives |
| 03/05/1998 | WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors |
| 03/05/1998 | WO1998001554A3 Secreted proteins and polynucleotides encoding them |
| 03/05/1998 | CA2264044A1 Spirocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2263928A1 Substituted cyclic amine metalloprotease inhibitors |
| 02/26/1998 | WO1998007854A1 Human glycine transporter |
| 02/24/1998 | US5721215 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 02/19/1998 | WO1998006278A1 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 02/18/1998 | CN1173373A Medicine for treating muscular tremor |
| 02/17/1998 | US5719186 Central muscle relaxants, anxiolytic agents, antiinflammatory agents, analgesics, anticonvulsants |
| 02/17/1998 | CA1339678C Atrial natriuretic peptide derivative, its production and use thereof for treating gardiac or cerebral circulatory disease |
| 02/12/1998 | WO1998005336A1 Inhibitors of cysteine protease |
| 02/11/1998 | EP0822812A1 Topical treatment and/or prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines |
| 02/10/1998 | US5716955 Cytokine inhibitor |
| 02/10/1998 | US5716930 Polypeptide from genetically engineered cells |
| 02/10/1998 | US5716632 Administering n-substituted 2-(1h)pyridones or 3-(1h)pyridones |
| 02/05/1998 | WO1997038084A3 Polynucleotides derived from a pbmc cdna library encoding secreted proteins |
| 02/04/1998 | EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/04/1998 | EP0821739A1 An adenovirus helper-virus system |
| 02/03/1998 | US5714607 Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
| 01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 01/22/1998 | WO1998002423A1 Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 01/22/1998 | WO1998002190A2 Cationic amphiphile/dna complexes |
| 01/22/1998 | CA2260034A1 Cationic amphiphile/dna complexes |
| 01/20/1998 | US5710140 Phenyl heterocycles as COX-2 inhibitors |
| 01/20/1998 | US5710139 Heterocyclic compounds |
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001128A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1998 | CN1036995C Imidazodiazepine, and its preparation and use |
| 01/13/1998 | US5708007 2-(piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl) benzofuran-7-ol and carbamate derivatives for treating memory dysfunction |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient |
| 01/08/1998 | WO1998000390A1 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
| 01/08/1998 | WO1998000173A2 Targeted drug delivery using sulfonamide derivatives |
| 01/08/1998 | WO1998000131A1 Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (als) |
| 01/08/1998 | CA2259316A1 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0814661A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9 |
| 12/31/1997 | WO1997049394A2 Sold oral dosage forms of valsartan |
| 12/30/1997 | US5703100 Modulators of acetylcholine receptors |
| 12/30/1997 | US5703091 Suitable for the control of diseases |
| 12/24/1997 | WO1997025333A3 Macrocyclic compounds made from suboxide units |
| 12/23/1997 | US5700778 Inhibit synaptic transmission |
| 12/18/1997 | WO1997035015A3 Tyrosine-phosphatase-related protein |
| 12/17/1997 | CN1168140A Hydroxymethyl imidazodiazepines and their esters |
| 12/13/1997 | CA2206219A1 A novel process for the manufacture of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo [1,5a] [1,4] benzodiazepine (midazolam) |
| 12/11/1997 | WO1997046256A1 Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| 12/10/1997 | EP0811384A1 Muscle protein decomposition inhibitor containing il-6 receptor antibody |
| 12/10/1997 | CN1167487A Oxazolyl-and thiazolylimidazo- and thienodiazepines and their use as medicaments |
| 12/04/1997 | WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
| 12/03/1997 | EP0809636A1 Substituted isoxazoles for the treatment of inflammation |
| 12/03/1997 | EP0809635A1 Alpha-substituted hydrazides having calpain inhibitory activity |